VICTORIA BROTHERS: Open Payments
NPI 1962143313 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,073 in 99 payments from 17 companies in 2025. Trend: 2023 $1,751 · 2024 $1,917 · 2025 $2,073
Food & beverage: $2,073
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $475 |
| GlaxoSmithKline, LLC. | 28 | $431 |
| Regeneron Healthcare Solutions, Inc. | 20 | $288 |
| GENZYME CORPORATION | 6 | $185 |
| Pulmonx Corporation | 1 | $149 |
| Verona Pharma, Inc. | 5 | $117 |
| Insmed, Inc. | 4 | $94 |
| Inspire Medical Systems, Inc. | 3 | $62 |
| Grifols USA, LLC | 4 | $62 |
| Merck Sharp & Dohme LLC | 3 | $59 |
Products named: DUPIXENT, NUCALA, FASENRA, TEZSPIRE, CHARTIS CATHETER, TRELEGY ELLIPTA, Ohtuvayre, Arikayce.
Industry payments across TX — which companies pay providers there.
